SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001160550-06-000003
Filing Date
2006-01-11
Accepted
2006-01-11 10:39:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS SCHEDULE 13G vertex.txt SC 13G 5411
  Complete submission text file 0001160550-06-000003.txt   6978
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42126 | Film No.: 06523852
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address PIAZZA CORDUSIO 2 MILAN ITALY L6 20123 011390288628660
UNICREDITO ITALIANO SPA (Filed by) CIK: 0001160550 (see all company filings)

Type: SC 13G